Targeted injection of a biocomposite material alters macrophage and fibroblast phenotype and function following myocardial infarction: Relation to left ventricular remodeling

Journal of Pharmacology and Experimental Therapeutics

Volumn 350, Issue 3, 2014, Pages 701-709

  McGarvey, Jeremy R ^c   Pettaway, Sara ^a   Shuman, James A ^a   Novack, Craig P ^a   Zellars, Kia N ^a   Freels, Parker D ^a   Echols, Randall L ^a   Burdick, Jason A ^b   Gorman, Joseph H ^c   Gorman, Robert C ^c   Spinale, Francis G ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CALCIUM HYDROXYAPATITE MICROSPHERE; MACROPHAGE INFLAMMATORY PROTEIN 1; MESSENGER RNA; SMOOTH MUSCLE ACTIN; UNCLASSIFIED DRUG; HYDROXYAPATITE; MICROSPHERE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; FIBROBLAST; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; MACROPHAGE; NONHUMAN; PORCINE MODEL; PRIORITY JOURNAL; ANIMAL; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; HEART VENTRICLE; INJECTION; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; RANDOMIZATION; SWINE;

ANIMALS; BIOCOMPATIBLE MATERIALS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; DURAPATITE; FIBROBLASTS; HEART VENTRICLES; INJECTIONS; MACROPHAGES; MICROSPHERES; MYOCARDIAL INFARCTION; PHENOTYPE; RANDOM ALLOCATION; SWINE; VENTRICULAR REMODELING;

EID: 84907285550     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.114.215798     Document Type: Article

References (44)

1. Ahn MS (2007) Calcium hydroxylapatite: Radiesse. Facial Plast Surg Clin North Am 15:85-90, vii.
2. Anzai A, Anzai T, Nagai S, Maekawa Y, Naito K, Kaneko H, Sugano Y, Takahashi T, Abe H, Mochizuki S, et al. (2012) Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling. Circulation 125:1234-1245.
3. Baum J and Duffy HS (2011) Fibroblasts and myofibroblasts: what are we talking about? J Cardiovasc Pharmacol 57:376-379.
4. Brown BN, Valentin JE, Stewart-Akers AM, McCabe GP, and Badylak SF (2009) Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 30:1482-1491.
5. Burdick JA, Mauck RL, Gorman JH, 3rd, and Gorman RC (2013) Acellular biomaterials: an evolving alternative to cell-based therapies. Sci Transl Med 5: 176-186.
6. Chapman RE, Scott AA, Deschamps AM, Lowry AS, Stroud RE, Ikonomidis JS, and Spinale FG (2003) Matrix metalloproteinase abundance in human myocardial fibroblasts: effects of sustained pharmacologic matrix metalloproteinase inhibition. J Mol Cell Cardiol 35:539-548.
7. Cohen HB and Mosser DM (2014) Cardiac macrophages: how to mend a broken heart. Immunity 40:3-5.
8. Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, Michael LH, Rollins BJ, Entman ML, and Frangogiannis NG (2005) CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res 96:881-889.
9. Dixon JA, Gaillard WF, 2nd, Rivers WT, Koval CN, Stroud RE, Mukherjee R, and Spinale FG (2010) Heterogeneity in MT1-MMP activity with ischemia-reperfusion and previous myocardial infarction: relation to regional myocardial function. Am J Physiol Heart Circ Physiol 299:H1947-H1958.
10. Dixon JA, Gorman RC, Stroud RE, Mukherjee R, Meyer EC, Baker NL, Morita M, Hamamoto H, Ryan LP, Gorman JH, 3rd, et al. (2011) Targeted regional injection of biocomposite microspheres alters post-myocardial infarction remodeling and matrix proteolytic pathways. Circulation 124(11, Suppl)S35-S45.
11. Eckhouse SR, Purcell BP, McGarvey JR, Lobb D, Logdon CB, Doviak H, O'Neill JW, Shuman JA, Novack CP, Zellars KN, et al. (2014) Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction. Sci Transl Med 6:223-233.
12. Epelman S, Lavine KJ, Beaudin AE, Sojka DK, Carrero JA, Calderon B, Brija T, Gautier EL, Ivanov S, Satpathy AT, et al. (2014) Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 40:91-104.
13. Ertl G and Frantz S (2005) Healing after myocardial infarction. Cardiovasc Res 66:22-32.
14. Frangogiannis NG (2012) Regulation of the inflammatory response in cardiac repair. Circ Res 110:159-173.
15. Freytes DO, Kang JW, Marcos-Campos I, and Vunjak-Novakovic G (2013) Macrophages modulate the viability and growth of human mesenchymal stem cells. J Cell Biochem 114:220-229.
16. Goldsmith EC, Bradshaw AD, and Spinale FG (2013) Cellular mechanisms of tissue fibrosis. 2. Contributory pathways leading to myocardial fibrosis: moving beyond collagen expression. Am J Physiol Cell Physiol 304:C393-C402.
17. Hohensinner PJ, Rychli K, Zorn G, Hülsmann M, Berger R, Mörtl D, Richter B, Huber K, Wojta J, Pacher R, et al. (2010) Macrophage-modulating cytokines predict adverse outcome in heart failure. Thromb Haemost 103:435-441.
18. Ifkovits JL, Tous E, Minakawa M, Morita M, Robb JD, Koomalsingh KJ, Gorman JH, 3rd, Gorman RC, and Burdick JA (2010) Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc Natl Acad Sci USA 107:11507-11512.
19. Ismahil MA, Hamid T, Bansal SS, Patel B, Kingery JR, and Prabhu SD (2014) Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis. Circ Res 114:266-282.
20. Jacovella PF (2008) Use of calcium hydroxylapatite (Radiesse) for facial augmentation. Clin Interv Aging 3:161-174.
21. Johnson TD and Christman KL (2013) Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction. Expert Opin Drug Deliv 10: 59-72.
22. Konstam MA, Kramer DG, Patel AR, Maron MS, and Udelson JE (2011) Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging 4:98-108.
23. Lambert JM, Lopez EF, and Lindsey ML (2008) Macrophage roles following myocardial infarction. Int J Cardiol 130:147-158.
24. Landa N, Miller L, Feinberg MS, Holbova R, Shachar M, Freeman I, Cohen S, and Leor J (2008) Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 117:1388-1396.
25. Lindsey ML, Goshorn DK, Squires CE, Escobar GP, Hendrick JW, Mingoia JT, Sweterlitsch SE, and Spinale FG (2005) Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function. Cardiovasc Res 66:410-419.
26. Lindsey M, Wedin K, Brown MD, Keller C, Evans AJ, Smolen J, Burns AR, Rossen RD, Michael L, and Entman M (2001) Matrix-dependent mechanism of neutrophilmediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation 103:2181-2187.
27. Ma Y, Halade GV, Zhang J, Ramirez TA, Levin D, Voorhees A, Jin YF, Han HC, Manicone AM, and Lindsey ML (2013) Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation. Circ Res 112:675-688.
28. Morita M, Eckert CE, Matsuzaki K, Noma M, Ryan LP, Burdick JA, Jackson BM, Gorman JH, 3rd, Sacks MS, and Gorman RC (2011) Modification of infarct material properties limits adverse ventricular remodeling. Ann Thorac Surg 92: 617-624.
29. Mukherjee R, Zavadzkas JA, Saunders SM, McLean JE, Jeffords LB, Beck C, Stroud RE, Leone AM, Koval CN, Rivers WT, et al. (2008) Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs. Ann Thorac Surg 86:1268-1276.
30. Nahrendorf M and Swirski FK (2013) Monocyte and macrophage heterogeneity in the heart. Circ Res 112:1624-1633.
31. Pilla JJ, Gorman JH, 3rd, and Gorman RC (2009) Theoretic impact of infarct compliance on left ventricular function. Ann Thorac Surg 87:803-810.
32. Rane AA, Chuang JS, Shah A, Hu DP, Dalton ND, Gu Y, Peterson KL, Omens JH, and Christman KL (2011) Increased infarct wall thickness by a bio-inert material is insufficient to prevent negative left ventricular remodeling after myocardial infarction. PLoS ONE 6:e21571.
33. Rodell CB, Kaminski AL, and Burdick JA (2013) Rational design of network properties in guest-host assembled and shear-thinning hyaluronic acid hydrogels. Biomacromolecules 14:4125-4134.
34. Shumaker PR, England LJ, Dover JS, Ross EV, Harford R, Derienzo D, Bogle M, Uebelhoer N, Jacoby M, and Pope K (2006) Effect of monopolar radiofrequency treatment over soft-tissue fillers in an animal model: part 2. Lasers Surg Med 38: 211-217.
35. Shuman JA, Zurcher JR, Sapp AA, Burdick JA, Gorman RC, Gorman JH, 3rd, Goldsmith EC, and Spinale FG (2013) Localized targeting of biomaterials following myocardial infarction: a foundation to build on. Trends Cardiovasc Med 23:301-311.
36. Spinale FG (2007) Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87:1285-1342.
37. Spinale FG, Janicki JS, and Zile MR (2013) Membrane-associated matrix proteolysis and heart failure. Circ Res 112:195-208.
38. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, and Brown RA (2002) Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3:349-363.
39. Tous E, Ifkovits JL, Koomalsingh KJ, Shuto T, Soeda T, Kondo N, Gorman JH, 3rd, Gorman RC, and Burdick JA (2011) Influence of injectable hyaluronic acid hydrogel degradation behavior on infarction-induced ventricular remodeling. Biomacromolecules 12:4127-4135.
40. Tous E, Weber HM, Lee MH, Koomalsingh KJ, Shuto T, Kondo N, Gorman JH, 3rd, Lee D, Gorman RC, and Burdick JA (2012) Tunable hydrogel-microsphere composites that modulate local inflammation and collagen bulking. Acta Biomater 8:3218-3227.
41. van der Laan AM, Ter Horst EN, Delewi R, Begieneman MP, Krijnen PA, Hirsch A, Lavaei M, Nahrendorf M, Horrevoets AJ, Niessen HW, et al. (2014) Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir. Eur Heart J 35:376-385.
42. Webb CS, Bonnema DD, Ahmed SH, Leonardi AH, McClure CD, Clark LL, Stroud RE, Corn WC, Finklea L, Zile MR, et al. (2006) Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling. Circulation 114:1020-1027.
43. Widgerow AD (2011) Cellular/extracellular matrix cross-talk in scar evolution and control. Wound Repair Regen 19:117-133.
44. Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, and Gerig G (2006) User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31:1116-1128.